Distinct features for drug use-related endophthalmitis

November 20, 2017

(HealthDay)—Patients with injection drug use (IDU) endogenous endophthalmitis (EE) are younger, with fewer comorbidities, and have more improvement in visual acuity after intervention compared with non-IDU EE patients, according to a research letter published online Nov. 16 in JAMA Ophthalmology.

Preston M. Luong, from Geisel School of Medicine at Dartmouth in Hanover, New Hampshire, and colleagues conducted a retrospective medical record review identifying EE cases from Jan. 1, 2012, through Dec. 5, 2016, to examine the clinical characteristics of IDU versus non-IDU EE.

The researchers identified 15 with EE (five males and 10 females), of whom nine had a history of IDU. The number of non-IDU EE cases remained at zero to two per year during the study period, while the number of IDU EE cases varied from zero to four per year; the most cases occurred in 2016. The most common presenting symptom was reduced vision, which was seen for all nine patients with IDU EE and five of the six patients with non-IDU EE. Patients with IDU were younger, had fewer comorbidities, and tended to delay seeking medical care. In addition, they had more negative intraocular and blood culture findings for EE, and they experienced significantly more improvement in after intervention.

"The patients with IDU represent a younger and healthier subset of the population with EE and may regain vision with prompt recognition and treatment," the authors write.

Explore further: Cases of low vision, blindness estimated to double in 30 years

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Cases of low vision, blindness estimated to double in 30 years

November 3, 2017
(HealthDay)—Prevalence and incidence rates of low vision and blindness demonstrate a growing need for low vision rehabilitation services in the United States, according to a study published online Nov. 2 in JAMA Ophthalmology.

Facility volume found to impact nasopharyngeal CA survival

November 6, 2017
(HealthDay)—Treatment at a high-volume facility (HVF) is a significant predictor of improved overall survival in nasopharyngeal cancer (NPC), according to a research letter published online Nov. 2 in JAMA Otolaryngology—Head ...

Self-care tools cut depression in AMD, diabetic retinopathy

December 14, 2016
(HealthDay)—Self-care tools can reduce depressive symptoms in patients with age-related macular degeneration (AMD) or diabetic retinopathy (DR), according to a study published online Dec. 7 in Clinical & Experimental Ophthalmology.

Rise in endogenous Klebsiella pneumoniae endophthalmitis

September 2, 2016
(HealthDay)—Increasing trends of endogenous Klebsiella pneumoniae endophthalmitis (EKPE) have been reported in Australia, according to research published online Aug. 26 in Clinical & Experimental Ophthalmology.

Amblyopia Tx at young age results in good vision later

July 16, 2014
(HealthDay)—Most children treated for moderate amblyopia when younger than 7 years have good visual acuity at 15 years of age, according to a study published in the July issue of JAMA Ophthalmology.

Wound leak critical complication post open globe repair

March 4, 2015
(HealthDay)—Postoperative wound leak affects a substantial proportion of eyes following repair of open globe injuries, according to a study published online Feb. 17 in Clinical & Experimental Ophthalmology.

Recommended for you

Older adults with small social networks less likely to get cataract surgery

March 9, 2018
Close family relationships and a strong social network may help older adults see the world better—literally.

A retinal implant that is more effective against blindness

March 9, 2018
EPFL researchers have developed a new type of retinal implant for people who have become blind due to the loss of photoreceptor cells in their retinas. The implant partially restores their visual field and can significantly ...

New imaging technique could improve the diagnosis, treatment of glaucoma

March 7, 2018
The National Eye Institute, part of the National Institutes of Health, projects the number of Americans affected by glaucoma will more than double between 2010 and 2050, from 2.7 million to 6.3 million.

New gene therapy corrects a form of inherited macular degeneration in canine model

March 5, 2018
Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model. The work sets the stage for translating the findings into a human therapy ...

New insights into how the retina processes orientation

February 26, 2018
In a study published in Nature Communications, Northwestern Medicine scientists detail the discovery of two types of cells in the retina that determine horizontal or vertical orientation, and demonstrated for the first time ...

Glaucoma study finds brain fights to preserve vision

February 23, 2018
A team of researchers, led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.